$LWLG Website has varied

New Post Public Reply Private Reply Replies (0) Message Board
mc67
380
$LWLG Website has varied updates:

http://lightwavelogic.com/

Our Technology Foundation

Lightwave Logic’s technology is based on its breakthrough Perkinamine™ family of electro-optic chromophores.

These materials are thermally stable and robust, are electro-optically active and have excellent high-frequency properties.

Our family of organic polymer systems has demonstrated the ability to withstand processing temperatures of 180 degrees Celsius and are CMOS and photo-chemically stable.

Because our polymers are initially in liquid form, they can be deposited into many different optical structures and platforms such as silicon photonics .

Using microfabrication technology to form waveguide structures, a large variety of polymer photonic devices and integrated circuits can be formed, including modulator arrays for encoding data at rates of 100’s of Gigabits per second (Gbps) that can potentially enable 400Gbps data rates and beyond.

Organic Electro-Optic (EO) Polymer Technology Platform

Lightwave Logic’s material development technology goes beyond the chemical synthesis of organic chromophores (dyes) used to create of electro-optical and all-optical polymer materials.

Our technology platform is more accurately viewed as a material system that also includes spacer systems, host polymers, poling protocols, and cladding materials.

These custom and specifically designed material systems are primarily intended for use in our proprietary photonic device platform designs.

Proprietary Spacer Systems:

Because of a tendency of one end of an organic chromophore to attract to the other end (dimerization) an important part of our intellectual property is the development of complex spacer systems to prevent the degrading effect of this process.

This patented process allows the alignment of the molecular structure, which facilitates the electro-optic activity.

Thermal Stability of the polymer material:

One of the key competitive advantages of our polymer solution is the ability to withstand standard CMOS processing temperatures and retain strong electro-optical activity.

This gives our polymers the ability to integrate with standard semiconductor manufacturing processes.

After process stability, it is equally important that our organic polymers withstand often-harsh operating temperatures that can be as high as 85 degrees Celsius.

Test results indicate that our polymer materials maintain their electro-optic properties even after 2000 hours at 110 degrees Celsius, well beyond the temperatures of an operating communications network.

Photochemical Stability of the polymer material:

Our organic polymers have demonstrated excellent stability to resist photochemical bleaching that has been typical of organic polymers. To date, our polymer materials have demonstrated stable electro-optic characteristics after 4000 hours of photochemical stability testing

- SteveS

And this too

Polymer Device Platform

Lightwave Logic is developing in-house proprietary, EO-polymer photonic devices, integrated circuits and sub-systems with broad application in telecommunications, data communications, and data centers.

Ridge Waveguide Modulator: Lightwave Logic has announced the successful demonstration of its first two alpha-prototypes, ridge waveguide modulators that have adequate bandwidth for transmitting data rates of greater than 10 and 25 Gbps respectively.

The 25 Gbps device could be used in various 4 x 25 configurations to transmit 100 Gbps, a data rate of high interest for telecom and datacom markets. These miniaturized devices are more compact than the traditional lithium niobate modulators.

Next Generation Ultra-High Speed Modulators:

Building on its 25 Gbps-capable modulator, our technology team is developing advanced devices that will operate at 50 Gbps and multi-modulator Polymer PIC structures that will enable transmitters to operate at 100, 200 and 400 Gbps (e.g., (100Gbps composed of 4 x 25Gbps devices, 200Gbps composed of 4 devices of 50Gbps, and 400Gbps composed of 8 devices of 50Gbps).

The company’s P2IC™ platform with its potential for very low drive-voltage levels and ultra-miniaturization, is at the foundation of these advanced devices.

This has been updated

CAREERS

We are a fast-growing publically listed high technology company and we offer extremely competitive employment packages.

Our team is composed of world-class technologists. Our materials scientists synthesize new polymer materials to technical specifications driven by photonic device engineers who are creating a polymer PIC platform for the datacenter and high performance computing markets in fiber communications.

We are also implementing our technology into non-communication markets.

Our current job openings are listed below, but if you feel that you are truly world-class, you have the right experience base, and you believe you can add value to our technology platform (as seen from the photonics product roadmap webpage)

..then please feel free to submit your resume to:

resumes@lightwavelogic.com.

If you decide to submit your resume, please also write a short (less than 1 page) cover letter with a couple of succinct reasons why you should be considered to join our world-class team.

Our entrance hurdle is high, but not impossible should you have the experience and skill base to assist us in becoming the leading polymer photonic PIC technology player in the world.


Lightwave Logic Inc (LWLG) Stock Research Links

LWLG Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading